SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006537
Filing Date
2017-08-11
Accepted
2017-08-11 07:55:19
Documents
66
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mer-20170630x10q.htm 10-Q 1499552
2 EX-10.1 mer-20170630ex101c250d6.htm EX-10.1 37853
3 EX-31.1 mer-20170630ex311c14ab1.htm EX-31.1 13042
4 EX-31.2 mer-20170630ex312d2937e.htm EX-31.2 13076
5 EX-32 mer-20170630xex32.htm EX-32 15606
  Complete submission text file 0001558370-17-006537.txt   6025547

Data Files

Seq Description Document Type Size
6 EX-101.INS mer-20170630.xml EX-101.INS 1119437
7 EX-101.SCH mer-20170630.xsd EX-101.SCH 60527
8 EX-101.CAL mer-20170630_cal.xml EX-101.CAL 36206
9 EX-101.DEF mer-20170630_def.xml EX-101.DEF 230445
10 EX-101.LAB mer-20170630_lab.xml EX-101.LAB 439810
11 EX-101.PRE mer-20170630_pre.xml EX-101.PRE 359618
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 171022991
SIC: 2834 Pharmaceutical Preparations